Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129129) titled 'A Randomized, Double-Blind, Controlled Clinical Study Comparing Shen Zhuo Formula and Finerenone in Reducing Composite Endpoint Events in Patients with Diabetic Kidney Disease' on July 31.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Hangzhou Traditional Chinese Medicine Hospital
Condition:
Diabetic nephropathy
Intervention:
Trial group:Standard therapy + Shenzhuo Formula + Finerenone placebo. Participants in the experimental group will receive standard therapy combined with Shenzhuo Formula and finerenone placebo. Standard therapy includes lifestyle intervention (diet control an...